Logo1
ICCS - Annual Clinical Cytometry course 2021 PACE
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV/technology.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
The instructor was knowledgeable about the content
Objective 1: increase their knowledge of the role of clinical flow cytometry in the diagnosis of hematolymphoid malignancies
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
The instructor presented the subject matter clearly
Objective 2: become familiar with recent advances in technology, techniques, and approaches in clinical flow cytometry
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
The instructor was responsive to participants
Objective 3: better understand techniques for analysis of clinical flow cytometry data
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
The teaching methods used were appropriate to the objectives
The instructor used technology effectively
Describe the utility of flow cytometry in the diagnosis of benign and malignant hematolymphoid disorders
Recognize the components of a flow cytometer
Describe an approach to panel design for a flow cytometry assay and what elements should be considered
The instructor used technology effectively
Recognize normal myeloid and lymphoid populations and their maturation patterns by flow cytometry
Use flow cytometry to analyze normal hematolymphoid populations in lymph nodes, bone marrows, and peripheral blood
The instructor used technology effectively
Recognize normal components of bone marrow on bivariate dot plots of flow cytometry data
Describe how assigning colors to different populations can be used to define both normal and abnormal differentiation
Identify normal and abnormal B cell populations and discuss the utility of flow cytometry in the classification of B cell lymphomas
The instructor used technology effectively
Identify aberrant B cell and plasma cell populations and use flow cytometry to classify B cell lymphomas and plasma cell neoplasms
Identify aberrant mature T cell populations and use flow cytometry to identify and classify T cell lymphomas
The instructor used technology effectively
Define factors that are taken into account to determine validation strategies
Define assay-specific points for validation, including the conversion from an IVD to an LDT
Discuss Procedure and Quality Assurance aspect of assay validation, Quality Control, and related CAP checklist items
The instructor used technology effectively
Identify normal and abnormal immature myeloid and lymphoid populations using flow cytometry
Use flow cytometry data to diagnose and classify cases of acute leukemia
The instructor used technology effectively
Identify normal and abnormal T cell populations and discuss the utility of flow cytometry in the classification of T cell lymphomas
Identify normal and abnormal plasma cell populations and discuss the utility of flow cytometry in the classification of plasma cell neoplasms
Use flow cytometry data to diagnose and classify cases of acute leukemia
The instructor used technology effectively
Use flow cytometry data to diagnose and classify cases of myeloid neoplasms
Discuss the role of flow cytometry in the diagnosis of myelodysplastic syndromes and correlate with morphologic and clinical findings
Use flow cytometry data to recognize and diagnose small populations of residual leukemia
Please tell us about any sessions you found particularly good or bad.
Please tell us about any objectives you feel we accomplished well or poorly. 
Please tell us about any presenters you found particularly good or bad.
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

How did you attend this course?
Mr question
Provided by amedco